Rekah Pharmaceutical Prod Ltd. Logo

Rekah Pharmaceutical Prod Ltd.

A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.

REKA | TA

Overview

Corporate Details

ISIN(s):
IL0010810096
LEI:
Country:
Israel
Address:
Hamelaha 30, 5881904 Holon
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rekah Pharmaceutical Prod Ltd. is a generic pharmaceuticals manufacturer with over 70 years of industry experience. The company is active across the entire value chain, from research and development to production, marketing, sales, distribution, import, and export. Its portfolio features over 400 registered products, including generic prescription (Rx) and over-the-counter (OTC) drugs, medical devices, dermo-cosmetics, vitamins, and nutritional supplements. Rekah has in-depth expertise in specific therapeutic categories, specializing in the manufacturing of steroidal tablets, antibiotics, and ophthalmic products. The company focuses on expanding its international footprint through strategic collaborations, co-development partnerships, and licensing agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Rekah Pharmaceutical Prod Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Rekah Pharmaceutical Prod Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Rekah Pharmaceutical Prod Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.